266,723 Shares in Solventum Co. (NYSE:SOLV) Acquired by Ananym Capital Management LP

Ananym Capital Management LP acquired a new position in Solventum Co. (NYSE:SOLV - Free Report) in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The fund acquired 266,723 shares of the company's stock, valued at approximately $17,620,000. Solventum comprises approximately 9.7% of Ananym Capital Management LP's investment portfolio, making the stock its 6th largest position. Ananym Capital Management LP owned 0.15% of Solventum as of its most recent SEC filing.

Several other institutional investors have also recently bought and sold shares of SOLV. Clarity Asset Management Inc. bought a new stake in shares of Solventum during the 4th quarter valued at $25,000. Stonebridge Financial Group LLC bought a new stake in shares of Solventum during the 4th quarter valued at $26,000. Raiffeisen Bank International AG bought a new stake in shares of Solventum during the 4th quarter valued at $29,000. Crews Bank & Trust bought a new stake in shares of Solventum during the 4th quarter valued at $32,000. Finally, Colonial Trust Co SC raised its position in shares of Solventum by 240.7% during the 4th quarter. Colonial Trust Co SC now owns 511 shares of the company's stock valued at $34,000 after acquiring an additional 361 shares during the last quarter.

Solventum Price Performance

Shares of NYSE SOLV opened at $72.84 on Thursday. The firm has a market cap of $12.60 billion and a PE ratio of 33.72. The company has a current ratio of 1.15, a quick ratio of 0.83 and a debt-to-equity ratio of 2.45. Solventum Co. has a 1-year low of $47.16 and a 1-year high of $85.92. The company has a fifty day moving average price of $69.85 and a 200 day moving average price of $71.32.

Solventum (NYSE:SOLV - Get Free Report) last announced its earnings results on Thursday, May 8th. The company reported $1.34 earnings per share for the quarter, topping analysts' consensus estimates of $1.19 by $0.15. The company had revenue of $2.07 billion during the quarter, compared to analyst estimates of $2.02 billion. During the same period in the previous year, the company posted $2.08 earnings per share. Solventum's revenue for the quarter was up 2.7% on a year-over-year basis. Research analysts predict that Solventum Co. will post 6.58 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

Several analysts have commented on SOLV shares. Piper Sandler upgraded shares of Solventum from a "neutral" rating to an "overweight" rating and upped their target price for the company from $78.00 to $87.00 in a research report on Monday. The Goldman Sachs Group upped their target price on shares of Solventum from $63.00 to $71.00 and gave the company a "sell" rating in a research report on Monday, March 3rd. Wells Fargo & Company upped their target price on shares of Solventum from $73.00 to $75.00 and gave the company an "equal weight" rating in a research report on Friday, February 28th. Bank of America upped their target price on shares of Solventum from $80.00 to $85.00 and gave the company a "neutral" rating in a research report on Wednesday, February 26th. Finally, Mizuho upped their price objective on shares of Solventum from $70.00 to $82.00 and gave the company a "neutral" rating in a research report on Monday, March 3rd. One analyst has rated the stock with a sell rating, seven have assigned a hold rating and two have issued a buy rating to the company's stock. According to MarketBeat.com, the stock presently has a consensus rating of "Hold" and a consensus target price of $80.29.

Solventum Profile

Solventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. It operates through four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration.

Want to see what other hedge funds are holding SOLV? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Solventum Co. (NYSE:SOLV - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.